Membrane transporters in a human genome-scale metabolic knowledgebase and their implications for disease

Frontiers in Physiology

Volumn 5 MAR, Issue , 2014, Pages

  Sahoo, Swagatika ^a,b   Aurich, Maike K ^a,b   Jonsson, Jon J ^a,c   Thiele, Ines ^a,b  

^a UNIVERSITY OF ICELAND   (Iceland)

^b UNIVERSITY OF LUXEMBOURG   (Luxembourg)

^c LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

Author keywords

Cancer; Constraint based modeling; Human metabolism; Inborn errors of metabolism; Metabolic networks and pathways; Transport mechanisms

Indexed keywords

AMINO ACID TRANSPORTER; AQUAPORIN; ASCORBIC ACID; BETAINE; BIOTIN; CARNITINE; CARRIER PROTEIN; CHOLESTEROL; CYANOCOBALAMIN; FOLIC ACID; GLUCOSE TRANSPORTER; HEME; LIPOPROTEIN; NICOTINAMIDE; NUCLEOSIDE TRANSPORTER; PANTOTHENIC ACID; PYRIDOXINE; RIBOFLAVIN; SODIUM GLUCOSE COTRANSPORTER; TAURINE; THIAMINE; VITAMIN;

AMINO ACID TRANSPORT; CARBOHYDRATE TRANSPORT; CHOLESTEROL TRANSPORT; DISEASE ASSOCIATION; FATTY ACID TRANSPORT; HUMAN; KNOWLEDGE BASE; LIPID TRANSPORT; METABOLIC DISORDER; NEOPLASM; NUCLEOSIDE TRANSPORT; PROTEIN TRANSPORT; REVIEW; TRANSPORT KINETICS; WATER TRANSPORT;

EID: 84897931922     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2014.00091     Document Type: Review

References (227)

1. Adibi, S. A. (2003). Regulation of expression of the intestinal oligopeptide transporter (Pept-1) in health and disease. Am. J. Physiol. Gastrointest. Liver Physiol. 285, G779-G788. doi: 10.1152/ajpgi.00056.2003.
2. Agren, R., Bordel, S., Mardinoglu, A., Pornputtapong, N., Nookaew, I., and Nielsen, J. (2012). Reconstruction of genome-scale active metabolic networks for 69 human cell types and 16 cancer types using INIT. PLoS Comput. Biol. 8:e1002518. doi: 10.1371/journal.pcbi.1002518.
3. Agu, R., Cowley, E., Shao, D., Macdonald, C., Kirkpatrick, D., Renton, K., et al. (2011). Proton-coupled oligopeptide transporter (POT) family expression in human nasal epithelium and their drug transport potential. Mol. Pharm. 8, 664-672. doi: 10.1021/mp100234z.
4. Alberts, B., Johnson, A., and Lewis, J. (2002). Molecular Biology of the Cell. New York, NY: Garland Science.
5. Amaral, M. D., and Kunzelmann, K. (2007). Molecular targeting of CFTR as a therapeutic approach to cystic fibrosis. Trends Pharmacol. Sci. 28, 334-341. doi: 10.1016/j.tips.2007.05.004.
6. Amin, K. A., and Nagy, M. A. (2009). Effect of carnitine and herbal mixture extract on obesity induced by high fat diet in rats. Diabetol. Metab. Syndr. 1, 17. doi: 10.1186/1758-5996-1-17.
7. + clearance associated with aquaporin-4 mislocalization: phenotypic defects in brains of alpha-syntrophin-null mice. Proc. Natl. Acad. Sci. U.S.A. 100, 13615-13620. doi: 10.1073/pnas.2336064100.
8. +-and Cl(-)-dependent TauT (SLC6A6). J. Physiol. 587, 731-744. doi: 10.1113/jphysiol.2008.164228.
9. Augustin, R. (2010). The protein family of glucose transport facilitators: It's not only about glucose after all. IUBMB Life 62, 315-333. doi: 10.1002/iub.315.
10. Badagnani, I., Castro, R. A., Taylor, T. R., Brett, C. M., Huang, C. C., Stryke, D., et al. (2006). Interaction of methotrexate with organic-anion transporting polypeptide 1A2 and its genetic variants. J. Pharmacol. Exp. Ther. 318, 521-529. doi: 10.1124/jpet.106.104364.
11. Baird, F. E., Bett, K. J., Maclean, C., Tee, A. R., Hundal, H. S., and Taylor, P. M. (2009). Tertiary active transport of amino acids reconstituted by coexpression of System A and L transporters in Xenopus oocytes. Am. J. Physiol. Endocrinol. Metab. 297, E822-E829. doi: 10.1152/ajpendo.00330.2009.
12. Bakirtzi, K., Belfort, G., Lopez-Coviella, I., Kuruppu, D., Cao, L., Abel, E. D., et al. (2009). Cerebellar neurons possess a vesicular compartment structurally and functionally similar to Glut4-storage vesicles from peripheral insulin-sensitive tissues. J. Neurosci. 29, 5193-5201. doi: 10.1523/JNEUROSCI.0858-09.2009.
13. Baldwin, S. A., Beal, P. R., Yao, S. Y., King, A. E., Cass, C. E., and Young, J. D. (2004). The equilibrative nucleoside transporter family, SLC29. Pflugers Arch. 447, 735-743. doi: 10.1007/s00424-003-1103-2.
14. Ball, G. F. M. (2006). Vitamins: Their Role in the Human Body. Hoboken, NJ: Blackwell publishing.
15. Barnes, K., Dobrzynski, H., Foppolo, S., Beal, P. R., Ismat, F., Scullion, E. R., et al. (2006). Distribution and functional characterization of equilibrative nucleoside transporter-4, a novel cardiac adenosine transporter activated at acidic pH. Circ. Res. 99, 510-519. doi: 10.1161/01.RES.0000238359.18495.42.
16. Bates, C. J. (1997). Bioavailability of riboflavin. Eur. J. Clin. Nutr. 51(Suppl. 1), S38-S42.
17. Berry, D. C., Jin, H., Majumdar, A., and Noy, N. (2011). Signaling by vitamin A and retinol-binding protein regulates gene expression to inhibit insulin responses. Proc. Natl. Acad. Sci. U.S.A. 108, 4340-4345. doi: 10.1073/pnas.1011115108.
18. Bianchi, L., and Diez-Sampedro, A. (2010). A single amino acid change converts the sugar sensor SGLT3 into a sugar transporter. PLoS ONE 5:e10241. doi: 10.1371/journal.pone.0010241.
19. +/peptide symporter PEPT2: structure-affinity relationships. Amino Acids 31, 137-156. doi: 10.1007/s00726-006-0331-0.
20. Bordbar, A., Feist, A. M., Usaite-Black, R., Woodcock, J., Palsson, B. O., and Famili, I. (2011a). A multi-tissue type genome-scale metabolic network for analysis of whole-body systems physiology. BMC Syst. Biol. 5:180. doi: 10.1186/1752-0509-5-180.
21. Bordbar, A., Jamshidi, N., and Palsson, B. O. (2011b). iAB-RBC-283: a proteomically derived knowledge-base of erythrocyte metabolism that can be used to simulate its physiological and patho-physiological states. BMC Syst. Biol. 5:110. doi: 10.1186/1752-0509-5-110.
22. Bordbar, A., Lewis, N. E., Schellenberger, J., Palsson, B. O., and Jamshidi, N. (2010). Insight into human alveolar macrophage and M. tuberculosis interactions via metabolic reconstructions. Mol. Syst. Biol. 6, 422. doi: 10.1038/msb.2010.68.
23. Boyer, J. C., Campbell, C. E., Sigurdson, W. J., and Kuo, S. M. (2005). Polarized localization of vitamin C transporters, SVCT1 and SVCT2, in epithelial cells. Biochem. Biophys. Res. Commun. 334, 150-156. doi: 10.1016/j.bbrc.2005.06.069.
24. Broer, S. (2008). Amino acid transport across mammalian intestinal and renal epithelia. Physiol. Rev. 88, 249-286. doi: 10.1152/physrev.00018.2006.
25. Broer, S., and Palacin, M. (2011). The role of amino acid transporters in inherited and acquired diseases. Biochem. J. 436, 193-211. doi: 10.1042/BJ20101912.
26. Brunton, L., Lazo, J., and Parker, K. (2006). Goodman and Gilman's: The Pharmacological Basis of Therapeutics. New York, NY: The McGraw-Hill companies.
27. Burke, T. R., and Tsang, S. H. (2011). Allelic and phenotypic heterogeneity in ABCA4 mutations. Ophthalmic Genet. 32, 165-174. doi: 10.3109/13816810.2011.565397.
28. Cairns, R. A., Harris, I. S., and Mak, T. W. (2011). Regulation of cancer cell metabolism. Nat. Rev. Cancer 11, 85-95. doi: 10.1038/nrc2981.
29. Calvo, M. B., Figueroa, A., Pulido, E. G., Campelo, R. G., and Aparicio, L. A. (2010). Potential role of sugar transporters in cancer and their relationship with anticancer therapy. Int. J. Endocrinol. 2010:205357. doi: 10.1155/2010/205357.
30. Camacho, J., and Rioseco-Camacho, N. (1993). Hyperornithinemia-Hyperammonemia-Homocitrullinuria Syndrome. Seattle, WA: University of Washington.
31. Chabowski, A., Gorski, J., Luiken, J. J., Glatz, J. F., and Bonen, A. (2007). Evidence for concerted action of FAT/CD36 and FABPpm to increase fatty acid transport across the plasma membrane. Prostaglandins Leukot. Essent. Fatty Acids 77, 345-353. doi: 10.1016/j.plefa.2007.10.017.
32. Chang, R. L., Xie, L., Bourne, P. E., and Palsson, B. O. (2010). Drug off-target effects predicted using structural analysis in the context of a metabolic network model. PLoS Comput. Biol. 6:e1000938. doi: 10.1371/journal.pcbi.1000938.
33. Charrier, L., and Merlin, D. (2006). The oligopeptide transporter hPepT1: gateway to the innate immune response. Lab. Invest. 86, 538-546. doi: 10.1038/labinvest.3700423.
34. Chen, J., Williams, S., Ho, S., Loraine, H., Hagan, D., Whaley, J. M., et al. (2010). Quantitative PCR tissue expression profiling of the human SGLT2 gene and related family members. Diabetes Ther. 1, 57-92. doi: 10.1007/s13300-010-0006-4.
35. Closs, E. I., Boissel, J. P., Habermeier, A., and Rotmann, A. (2006). Structure and function of cationic amino acid transporters (CATs). J. Membr. Biol. 213, 67-77. doi: 10.1007/s00232-006-0875-7.
36. Cooper, R., Sarioglu, S., Sokmen, S., Fuzun, M., Kupelioglu, A., Valentine, H., et al. (2003). Glucose transporter-1 (GLUT-1): a potential marker of prognosis in rectal carcinoma? Br. J. Cancer 89, 870-876. doi: 10.1038/sj.bjc.6601202.
37. Coothankandaswamy, V., Elangovan, S., Singh, N., Prasad, P. D., Thangaraju, M., and Ganapathy, V. (2013). The plasma membrane transporter SLC5A8 suppresses tumour progression through depletion of survivin without involving its transport function. Biochem. J. 450, 169-178. doi: 10.1042/BJ20121248.
38. Corpe, C. P., Eck, P., Wang, J., Al-Hasani, H., and Levine, M. (2013). Intestinal dehydroascorbic acid (DHA) transport mediated by the facilitative sugar transporters, GLUT2 and GLUT8. J. Biol. Chem. 288, 9092-9101. doi: 10.1074/jbc.M112.436790.
39. Craig, S. A. (2004). Betaine in human nutrition. Am. J. Clin. Nutr. 80, 539-549.
40. Cura, A. J., and Carruthers, A. (2012). The role of monosaccharide transport proteins in carbohydrate assimilation, distribution, metabolism and homeostasis. Compr. Physiol. 2, 863-914. doi: 10.1002/cphy.c110024.
41. Czeizel, A. E. (1996). Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. Am. J. Med. Genet. 62, 179-183. doi: 10.1002/(SICI)1096-8628(19960315)62:2<179::AID-AJMG12>3.0.CO;2-L.
42. Czeizel, A. E., and Dudas, I. (1992). Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N. Engl. J. Med. 327, 1832-1835. doi: 10.1056/NEJM199212243272602.
43. Devaux, P. F., Herrmann, A., Ohlwein, N., and Kozlov, M. M. (2008). How lipid flippases can modulate membrane structure. Biochim. Biophys. Acta 1778, 1591-1600. doi: 10.1016/j.bbamem.2008.03.007.
44. Diez-Sampedro, A., Hirayama, B. A., Osswald, C., Gorboulev, V., Baumgarten, K., Volk, C., et al. (2003). A glucose sensor hiding in a family of transporters. Proc. Natl. Acad. Sci. U.S.A. 100, 11753-11758. doi: 10.1073/pnas.1733027100.
45. Diop-Bove, N., Kronn, D., and Goldman, I. D. (1993). Hereditary Folate Malabsorption. Seattle, WA: University of Washington.
46. Doblado, M., and Moley, K. H. (2009). Facilitative glucose transporter 9, a unique hexose and urate transporter. Am. J. Physiol. Endocrinol. Metab. 297, E831-E835. doi: 10.1152/ajpendo.00296.2009.
47. Duarte, N. C., Becker, S. A., Jamshidi, N., Thiele, I., Mo, M. L., Vo, T. D., et al. (2007). Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proc. Natl. Acad. Sci. U.S.A. 104, 1777-1782. doi: 10.1073/pnas.0610772104.
48. Dumas, M., Sadick, N. S., Noblesse, E., Juan, M., Lachmann-Weber, N., Boury-Jamot, M., et al. (2007). Hydrating skin by stimulating biosynthesis of aquaporins. J. Drugs Dermatol. 6, s20-s24.
49. Dusso, A. S., Brown, A. J., and Slatopolsky, E. (2005). Vitamin D. Am. J. Physiol. Renal Physiol. 289, F8-F28. doi: 10.1152/ajprenal.00336.2004.
50. Dutta-Roy, A. K. (2000). Cellular uptake of long-chain fatty acids: role of membrane-associated fatty-acid-binding/transport proteins. Cell. Mol. Life Sci. 57, 1360-1372. doi: 10.1007/PL00000621.
51. Enomoto, A., Wempe, M. F., Tsuchida, H., Shin, H. J., Cha, S. H., Anzai, N., et al. (2002). Molecular identification of a novel carnitine transporter specific to human testis. Insights into the mechanism of carnitine recognition. J. Biol. Chem. 277, 36262-36271. doi: 10.1074/jbc.M203883200.
52. Falasca, M., and Linton, K. J. (2012). Investigational ABC transporter inhibitors. Expert Opin. Investig. Drugs 21, 657-666. doi: 10.1517/13543784.2012.679339.
53. Febbraio, M., and Silverstein, R. L. (2007). CD36: implications in cardiovascular disease. Int. J. Biochem. Cell Biol. 39, 2012-2030. doi: 10.1016/j.biocel.2007.03.012.
54. Feron, O. (2009). Pyruvate into lactate and back: from the Warburg effect to symbiotic energy fuel exchange in cancer cells. Radiother. Oncol. 92, 329-333. doi: 10.1016/j.radonc.2009.06.025.
55. Flanagan, J. L., Simmons, P. A., Vehige, J., Willcox, M. D., and Garrett, Q. (2010). Role of carnitine in disease. Nutr. Metab. (Lond). 7, 30. doi: 10.1186/1743-7075-7-30.
56. Fletcher, J. I., Haber, M., Henderson, M. J., and Norris, M. D. (2010). ABC transporters in cancer: more than just drug efflux pumps. Nat. Rev. Cancer 10, 147-156. doi: 10.1038/nrc2789.
57. Folger, O., Jerby, L., Frezza, C., Gottlieb, E., Ruppin, E., and Shlomi, T. (2011). Predicting selective drug targets in cancer through metabolic networks. Mol. Syst. Biol. 7, 501. doi: 10.1038/msb.2011.35.
58. Forrest, L. R., Krämer, R., and Ziegler, C. (2011). The structural basis of secondary active transport mechanisms. Biochim. Biophys. Acta 1807, 167-188. doi: 10.1016/j.bbabio.2010.10.014.
59. Frezza, C., Zheng, L., Folger, O., Rajagopalan, K. N., Mackenzie, E. D., Jerby, L., et al. (2011). Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase. Nature 477, 225-228. doi: 10.1038/nature10363.
60. Fuchs, B. C., and Bode, B. P. (2005). Amino acid transporters ASCT2 and LAT1 in cancer: partners in crime? Semin. Cancer Biol. 15, 254-266. doi: 10.1016/j.semcancer.2005.04.005.
61. Fukasawa, Y., Segawa, H., Kim, J. Y., Chairoungdua, A., Kim, D. K., Matsuo, H., et al. (2000). Identification and characterization of a Na(+)-independent neutral amino acid transporter that associates with the 4F2 heavy chain and exhibits substrate selectivity for small neutral D-and L-amino acids. J. Biol. Chem. 275, 9690-9698. doi: 10.1074/jbc.275.13.9690.
62. Fukuda, Y., and Schuetz, J. D. (2012). ABC transporters and their role in nucleoside and nucleotide drug resistance. Biochem. Pharmacol. 83, 1073-1083. doi: 10.1016/j.bcp.2011.12.042.
63. Furuhashi, M., and Hotamisligil, G. S. (2008). Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat. Rev. Drug Discov. 7, 489-503. doi: 10.1038/nrd2589.
64. Fustin, J. M., Doi, M., Yamada, H., Komatsu, R., Shimba, S., and Okamura, H. (2012). Rhythmic nucleotide synthesis in the liver: temporal segregation of metabolites. Cell Rep. 1, 341-349. doi: 10.1016/j.celrep.2012.03.001.
65. Ganapathy, V., Thangaraju, M., and Prasad, P. D. (2009). Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond. Pharmacol. Ther. 121, 29-40. doi: 10.1016/j.pharmthera.2008.09.005.
66. Gille, C., Bolling, C., Hoppe, A., Bulik, S., Hoffmann, S., Hubner, K., et al. (2010). HepatoNet1: a comprehensive metabolic reconstruction of the human hepatocyte for the analysis of liver physiology. Mol. Syst. Biol. 6, 411. doi: 10.1038/msb.2010.62.
67. Glaser, B. (1993). Familial Hyperinsulinism. Seattle, WA: University of Washington.
68. Glatz, J. F., Luiken, J. J., and Bonen, A. (2010). Membrane fatty acid transporters as regulators of lipid metabolism: implications for metabolic disease. Physiol. Rev. 90, 367-417. doi: 10.1152/physrev.00003.2009.
69. Glavinas, H., Krajcsi, P., Cserepes, J., and Sarkadi, B. (2004). The role of ABC transporters in drug resistance, metabolism and toxicity. Curr. Drug Deliv. 1, 27-42. doi: 10.2174/1567201043480036.
70. Gopal, E., Fei, Y. J., Sugawara, M., Miyauchi, S., Zhuang, L., Martin, P., et al. (2004). Expression of slc5a8 in kidney and its role in Na(+)-coupled transport of lactate. J. Biol. Chem. 279, 44522-44532. doi: 10.1074/jbc.M405365200.
71. Gopal, E., Miyauchi, S., Martin, P. M., Ananth, S., Roon, P., Smith, S. B., et al. (2007). Transport of nicotinate and structurally related compounds by human SMCT1 (SLC5A8) and its relevance to drug transport in the mammalian intestinal tract. Pharm. Res. 24, 575-584. doi: 10.1007/s11095-006-9176-1.
72. Gossett, R. E., Frolov, A. A., Roths, J. B., Behnke, W. D., Kier, A. B., and Schroeder, F. (1996). Acyl-CoA binding proteins: multiplicity and function. Lipids 31, 895-918. doi: 10.1007/BF02522684.
73. Green, R. (2010). Ins and outs of cellular cobalamin transport. Blood 115, 1476-1477. doi: 10.1182/blood-2009-12-254037.
74. Grempler, R., Augustin, R., Froehner, S., Hildebrandt, T., Simon, E., Mark, M., et al. (2012). Functional characterisation of human SGLT-5 as a novel kidney-specific sodium-dependent sugar transporter. FEBS Lett. 586, 248-253. doi: 10.1016/j.febslet.2011.12.027.
75. Gropper, S. S., Smith, J. L., and Groff. J. L. (2009). Advanced Nutrition and Human Metabolism. Belmont, CA: Wadsworth, Cengage learning.
76. Guertin, F., Roy, C. C., Lepage, G., Perea, A., Giguere, R., Yousef, I., et al. (1991). Effect of taurine on total parenteral nutrition-associated cholestasis. JPEN J. Parenter. Enteral Nutr. 15, 247-251. doi: 10.1177/0148607191015003247.
77. Guyton, A. C., and Hall, J. E. (2000). Textbook of Medical Physiology. Philadelphia, PA: W. B. Saunders company.
78. Hamid, A., Kiran, M., Rana, S., and Kaur, J. (2009). Low folate transport across intestinal basolateral surface is associated with down-regulation of reduced folate carrier in in vivo model of folate malabsorption. IUBMB Life 61, 236-243. doi: 10.1002/iub.153.
79. Hansen, A. K., and Galtung, H. K. (2007). Aquaporin expression and cell volume regulation in the SV40 immortalized rat submandibular acinar cell line. Pflugers Arch. 453, 787-796. doi: 10.1007/s00424-006-0158-2.
80. Hara-Chikuma, M., and Verkman, A. S. (2008). Prevention of skin tumorigenesis and impairment of epidermal cell proliferation by targeted aquaporin-3 gene disruption. Mol. Cell. Biol. 28, 326-332. doi: 10.1128/MCB.01482-07.
81. Harrison, E. H. (2005). Mechanisms of digestion and absorption of dietary vitamin A. Annu. Rev. Nutr. 25, 87-103. doi: 10.1146/annurev.nutr.25.050304.092614.
82. +-and Cl(-)-coupled amino acid transporter ATB0,+ and expression of the transporter in tissues amenable for drug delivery. J. Pharmacol. Exp. Ther. 308, 1138-1147. doi: 10.1124/jpet.103.057109.
83. Hediger, M. A. (2002). New view at C. Nat. Med. 8, 445-446. doi: 10.1038/nm0502-445.
84. Hediger, M. A., Kanai, Y., You, G., and Nussberger, S. (1995). Mammalian ion-coupled solute transporters. J. Physiol. 482, 7S-17S.
85. Heller-Stilb, B., Van Roeyen, C., Rascher, K., Hartwig, H. G., Huth, A., Seeliger, M. W., et al. (2002). Disruption of the taurine transporter gene (taut) leads to retinal degeneration in mice. FASEB J. 16, 231-233. doi: 10.1096/fj.01-0691fje.
86. Hernández Patiño, C. E., Jaime-Muñoz, G., and Resendis-Antonio, O. (2013). Systems Biology of cancer: moving toward the integrative study of the metabolic alterations in cancer cells. Front. Physiol. 3:481. doi: 10.3389/fphys.2012.00481.
87. Hinoi, E., Takarada, T., Tsuchihashi, Y., and Yoneda, Y. (2005). Glutamate transporters as drug targets. Curr. Drug Targets CNS Neurol. Disord. 4, 211-220. doi: 10.2174/1568007053544093.
88. Ho, M. M., Ng, A. V., Lam, S., and Hung, J. Y. (2007). Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res. 67, 4827-4833. doi: 10.1158/0008-5472.CAN-06-3557.
89. Hollander, D., Rim, E., and Muralidhara, K. S. (1977). Vitamin K1 intestinal absorption in vivo: influence of luminal contents on transport. Am. J. Physiol. 232, E69-E74.
90. Hong, C., Maunakea, A., Jun, P., Bollen, A. W., Hodgson, J. G., Goldenberg, D. D., et al. (2005). Shared epigenetic mechanisms in human and mouse gliomas inactivate expression of the growth suppressor SLC5A8. Cancer Res. 65, 3617-3623. doi: 10.1158/0008-5472.CAN-05-0048.
91. Hoshide, R., Ikeda, Y., Karashima, S., Matsuura, T., Komaki, S., Kishino, T., et al. (1996). Molecular cloning, tissue distribution, and chromosomal localization of human cationic amino acid transporter 2 (HCAT2). Genomics 38, 174-178. doi: 10.1006/geno.1996.0613.
92. +/D-glucose cotransporters SGLT1 and SGLT2. Am. J. Physiol. Cell Physiol. 300, C14-C21. doi: 10.1152/ajpcell.00388.2010.
93. Hvidberg, V., Maniecki, M. B., Jacobsen, C., Hojrup, P., Moller, H. J., and Moestrup, S. K. (2005). Identification of the receptor scavenging hemopexin-heme complexes. Blood 106, 2572-2579. doi: 10.1182/blood-2005-03-1185.
94. Iannotti, L. L., Tielsch, J. M., Black, M. M., and Black, R. E. (2006). Iron supplementation in early childhood: health benefits and risks. Am. J. Clin. Nutr. 84, 1261-1276.
95. Ikonen, E. (2008). Cellular cholesterol trafficking and compartmentalization. Nat. Rev. Mol. Cell Biol. 9, 125-138. doi: 10.1038/nrm2336.
96. Jerby, L., and Ruppin, E. (2012). Predicting drug targets and biomarkers of cancer via genome-scale metabolic modeling. Clin. Cancer Res. 18, 5572-5584. doi: 10.1158/1078-0432.CCR-12-1856.
97. Jerby, L., Shlomi, T., and Ruppin, E. (2010). Computational reconstruction of tissue-specific metabolic models: application to human liver metabolism. Mol. Syst. Biol. 6, 401. doi: 10.1038/msb.2010.56.
98. Jerby, L., Wolf, L., Denkert, C., Stein, G. Y., Hilvo, M., Oresic, M., et al. (2012). Metabolic associations of reduced proliferation and oxidative stress in advanced breast cancer. Cancer Res. 72, 5712-5720. doi: 10.1158/0008-5472.CAN-12-2215.
99. Jia, Z., Pei, Z., Maiguel, D., Toomer, C. J., and Watkins, P. A. (2007). The fatty acid transport protein (FATP) family: very long chain acyl-CoA synthetases or solute carriers? J. Mol. Neurosci. 33, 25-31. doi: 10.1007/s12031-007-0038-z.
100. Joost, H. G., and Thorens, B. (2001). The extended GLUT-family of sugar/polyol transport facilitators: nomenclature, sequence characteristics, and potential function of its novel members (review). Mol. Membr. Biol. 18, 247-256. doi: 10.1080/09687680110090456.
101. Kanda, D., Takagi, H., Kawahara, Y., Yata, Y., Takakusagi, T., Hatanaka, T., et al. (2009). Novel large-scale deletion (whole exon 7) in the ABCC2 gene in a patient with the Dubin-Johnson syndrome. Drug Metab. Pharmacokinet. 24, 464-468. doi: 10.2133/dmpk.24.464.
102. Kantarci, S., Donnai, D., Noonan, K. M., and Pober, B. R. (1993). Donnai-Barrow Syndrome. Seattle, WA: University of Washington.
103. Karlstaedt, A., Fliegner, D., Kararigas, G., Ruderisch, H. S., Regitz-Zagrosek, V., and Holzhutter, H. G. (2012). CardioNet: a human metabolic network suited for the study of cardiomyocyte metabolism. BMC Syst. Biol. 6:114. doi: 10.1186/1752-0509-6-114.
104. Kendler, B. S. (2006). Supplemental conditionally essential nutrients in cardiovascular disease therapy. J. Cardiovasc. Nurs. 21, 9-16. doi: 10.1097/00005082-200601000-00004.
105. Kimelberg, H. K. (2005). Astrocytic swelling in cerebral ischemia as a possible cause of injury and target for therapy. Glia 50, 389-397. doi: 10.1002/glia.20174.
106. Kiss, K., Brozik, A., Kucsma, N., Toth, A., Gera, M., Berry, L., et al. (2012). Shifting the paradigm: the putative mitochondrial protein ABCB6 resides in the lysosomes of cells and in the plasma membrane of erythrocytes. PLoS ONE 7:e37378. doi: 10.1371/journal.pone.0037378.
107. Klaassen, C. D., and Aleksunes, L. M. (2010). Xenobiotic, bile acid, and cholesterol transporters: function and regulation. Pharmacol. Rev. 62, 1-96. doi: 10.1124/pr.109.002014.
108. Knoers, N. (1993). Nephrogenic Diabetes Insipidus. Seattle, WA: University of Washington.
109. Kobayashi, A., Masumura, Y., and Yamazaki, N. (1992). L-carnitine treatment for congestive heart failure-experimental and clinical study. Jpn. Circ. J. 56, 86-94. doi: 10.1253/jcj.56.86.
110. Kobayashi, K., Saheki, T., and Song, Y. Z. (1993). Citrin Deficiency. Seattle, WA: University of Washington.
111. Kothinti, R. K., Blodgett, A. B., North, P. E., Roman, R. J., and Tabatabai, N. M. (2012). A novel SGLT is expressed in the human kidney. Eur. J. Pharmacol. 690, 77-83. doi: 10.1016/j.ejphar.2012.06.033.
112. Krishnamurthy, P., Ross, D. D., Nakanishi, T., Bailey-Dell, K., Zhou, S., Mercer, K. E., et al. (2004). The stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interactions with heme. J. Biol. Chem. 279, 24218-24225. doi: 10.1074/jbc.M313599200.
113. Kristiansen, M., Aminoff, M., Jacobsen, C., De La Chapelle, A., Krahe, R., Verroust, P. J., et al. (2000). Cubilin P1297L mutation associated with hereditary megaloblastic anemia 1 causes impaired recognition of intrinsic factor-vitamin B(12) by cubilin. Blood 96, 405-409.
114. Leibach, F. H., and Ganapathy, V. (1996). Peptide transporters in the intestine and the kidney. Annu. Rev. Nutr. 16, 99-119. doi: 10.1146/annurev.nu.16.070196.000531.
115. Lewis, N. E., Schramm, G., Bordbar, A., Schellenberger, J., Andersen, M. P., Cheng, J. K., et al. (2010). Large-scale in silico modeling of metabolic interactions between cell types in the human brain. Nat. Biotechnol. 28, 1279-1285. doi: 10.1038/nbt.1711.
116. Li, H., Myeroff, L., Smiraglia, D., Romero, M. F., Pretlow, T. P., Kasturi, L., et al. (2003). SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers. Proc. Natl. Acad. Sci. U.S.A. 100, 8412-8417. doi: 10.1073/pnas.1430846100.
117. Liang, W. J., Johnson, D., and Jarvis, S. M. (2001). Vitamin C transport systems of mammalian cells. Mol. Membr. Biol. 18, 87-95. doi: 10.1080/09687680110033774.
118. Lo, M., Wang, Y. Z., and Gout, P. W. (2008). The x(c)-cystine/glutamate antiporter: a potential target for therapy of cancer and other diseases. J. Cell. Physiol. 215, 593-602. doi: 10.1002/jcp.21366.
119. Lodish, H., Berk, A., and Zipursky, S. L. (2000). Molecular Cell Biology: Uniporter-Catalyzed Transport. New York, NY: W. H. Freeman and Company.
120. Macaulay, N., Hamann, S., and Zeuthen, T. (2004). Water transport in the brain: role of cotransporters. Neuroscience 129, 1031-1044. doi: 10.1016/j.neuroscience.2004.06.045.
121. Macheda, M. L., Rogers, S., and Best, J. D. (2005). Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J. Cell. Physiol. 202, 654-662. doi: 10.1002/jcp.20166.
122. Marce, S., Molina-Arcas, M., Villamor, N., Casado, F. J., Campo, E., Pastor-Anglada, M., et al. (2006). Expression of human equilibrative nucleoside transporter 1 (hENT1) and its correlation with gemcitabine uptake and cytotoxicity in mantle cell lymphoma. Haematologica 91, 895-902.
123. Matherly, L. H., and Goldman, D. I. (2003). Membrane transport of folates. Vitam. Horm. 66, 403-456. doi: 10.1016/S0083-6729(03)01012-4.
124. McKay Hart, A., Wiberg, M., and Terenghi, G. (2002). Pharmacological enhancement of peripheral nerve regeneration in the rat by systemic acetyl-L-carnitine treatment. Neurosci. Lett. 334, 181-185. doi: 10.1016/S0304-3940(02)00982-5.
125. Miguel-Aliaga, I. (2012). Nerveless and gutsy: intestinal nutrient sensing from invertebrates to humans. Semin. Cell Dev. Biol. 23, 614-620. doi: 10.1016/j.semcdb.2012.01.002.
126. Mitsutake, S., Suzuki, C., Akiyama, M., Tsuji, K., Yanagi, T., Shimizu, H., et al. (2010). ABCA12 dysfunction causes a disorder in glucosylceramide accumulation during keratinocyte differentiation. J. Dermatol. Sci. 60, 128-129. doi: 10.1016/j.jdermsci.2010.08.012.
127. Miyauchi, S., Gopal, E., Fei, Y. J., and Ganapathy, V. (2004). Functional identification of SLC5A8, a tumor suppressor down-regulated in colon cancer, as a Na(+)-coupled transporter for short-chain fatty acids. J. Biol. Chem. 279, 13293-13296. doi: 10.1074/jbc.C400059200.
128. Molina-Arcas, M., Trigueros-Motos, L., Casado, F. J., and Pastor-Anglada, M. (2008). Physiological and pharmacological roles of nucleoside transporter proteins. Nucleosides Nucleotides Nucleic Acids 27, 769-778. doi: 10.1080/15257770802145819.
129. Morgan, N. V., Morris, M. R., Cangul, H., Gleeson, D., Straatman-Iwanowska, A., Davies, N., et al. (2010). Mutations in SLC29A3, encoding an equilibrative nucleoside transporter ENT3, cause a familial histiocytosis syndrome (Faisalabad histiocytosis) and familial Rosai-Dorfman disease. PLoS Genet. 6:e1000833. doi: 10.1371/journal.pgen.1000833.
130. Murray, R. K., Bender, D. A., Botham, K. M., Kennelly, P. J., Rodwell, V. W., and Weil, P. A. (2009). A Lange Medical Book: Harper's Illustrated Biochemistry. New York, NY: Mc Graw Hill Medical.
131. Nabokina, S. M., Kashyap, M. L., and Said, H. M. (2005). Mechanism and regulation of human intestinal niacin uptake. Am. J. Physiol. Cell Physiol. 289, C97-C103. doi: 10.1152/ajpcell.00009.2005.
132. Nakauchi, J., Matsuo, H., Kim, D. K., Goto, A., Chairoungdua, A., Cha, S. H., et al. (2000). Cloning and characterization of a human brain Na(+)-independent transporter for small neutral amino acids that transports D-serine with high affinity. Neurosci. Lett. 287, 231-235. doi: 10.1016/S0304-3940(00)01169-1.
133. Narushima, K., Takada, T., Yamanashi, Y., and Suzuki, H. (2008). Niemann-pick C1-like 1 mediates alpha-tocopherol transport. Mol. Pharmacol. 74, 42-49. doi: 10.1124/mol.107.043034.
134. Nelson, D. L., and Cox, M. M. (2000). Lehninger Principles of Biochemsitry. New York, NY: Worth publication.
135. Nickerson, J. G., Alkhateeb, H., Benton, C. R., Lally, J., Nickerson, J., Han, X. X., et al. (2009). Greater transport efficiencies of the membrane fatty acid transporters FAT/CD36 and FATP4 compared with FABPpm and FATP1 and differential effects on fatty acid esterification and oxidation in rat skeletal muscle. J. Biol. Chem. 284, 16522-16530. doi: 10.1074/jbc.M109.004788.
136. Ohashi, R., Tamai, I., Nezu Ji, J., Nikaido, H., Hashimoto, N., Oku, A., et al. (2001). Molecular and physiological evidence for multifunctionality of carnitine/organic cation transporter OCTN2. Mol. Pharmacol. 59, 358-366.
137. Orso, E., Broccardo, C., Kaminski, W. E., Bottcher, A., Liebisch, G., Drobnik, W., et al. (2000). Transport of lipids from golgi to plasma membrane is defective in tangier disease patients and Abc1-deficient mice. Nat. Genet. 24, 192-196. doi: 10.1038/72869.
138. Orth, J. D., Thiele, I., and Palsson, B. O. (2010). What is flux balance analysis? Nat. Biotechnol. 28, 245-248. doi: 10.1038/nbt.1614.
139. Palacin, M., Nunes, V., Font-Llitjos, M., Jimenez-Vidal, M., Fort, J., Gasol, E., et al. (2005). The genetics of heteromeric amino acid transporters. Physiology (Bethesda). 20, 112-124. doi: 10.1152/physiol.00051.2004.
140. Palsson, B. O. (2006). Systems Biology-Properties of Reconstructed Networks. Cambridge; New York: Cambridge University Press. doi: 10.1017/CBO9780511790515.
141. Pastor-Anglada, M., Errasti-Murugarren, E., Aymerich, I., and Casado, F. J. (2007). Concentrative nucleoside transporters (CNTs) in epithelia: from absorption to cell signaling. J. Physiol. Biochem. 63, 97-110. doi: 10.1007/BF03174089.
142. Pieri, M., Christian, H. C., Wilkins, R. J., Boyd, C. A., and Meredith, D. (2010). The apical (hPepT1) and basolateral peptide transport systems of Caco-2 cells are regulated by AMP-activated protein kinase. Am. J. Physiol. Gastrointest. Liver Physiol. 299, G136-G143. doi: 10.1152/ajpgi.00014.2010.
143. Pober, B. R., Longoni, M., and Noonan, K. M. (2009). A review of Donnai-Barrow and facio-oculo-acoustico-renal (DB/FOAR) syndrome: clinical features and differential diagnosis. Birth Defects Res. Part A Clin. Mol. Teratol. 85, 76-81. doi: 10.1002/bdra.20534.
144. Polisecki, E., Peter, I., Simon, J. S., Hegele, R. A., Robertson, M., Ford, I., et al. (2010). Genetic variation at the NPC1L1 gene locus, plasma lipoproteins, and heart disease risk in the elderly. J. Lipid Res. 51, 1201-1207. doi: 10.1194/jlr.P001172.
145. Pouyssegur, J., Dayan, F., and Mazure, N. M. (2006). Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 441, 437-443. doi: 10.1038/nature04871.
146. Prudente, S., Flex, E., Morini, E., Turchi, F., Capponi, D., De Cosmo, S., et al. (2007). A functional variant of the adipocyte glycerol channel aquaporin 7 gene is associated with obesity and related metabolic abnormalities. Diabetes 56, 1468-1474. doi: 10.2337/db06-1389.
147. Quadros, E. V. (2010). Advances in the understanding of cobalamin assimilation and metabolism. Br. J. Haematol. 148, 195-204. doi: 10.1111/j.1365-2141.2009.07937.x.
148. Reboul, E., and Borel, P. (2011). Proteins involved in uptake, intracellular transport and basolateral secretion of fat-soluble vitamins and carotenoids by mammalian enterocytes. Prog. Lipid Res. 50, 388-402. doi: 10.1016/j.plipres.2011.07.001.
149. Reboul, E., Goncalves, A., Comera, C., Bott, R., Nowicki, M., Landrier, J. F., et al. (2011). Vitamin D intestinal absorption is not a simple passive diffusion: evidences for involvement of cholesterol transporters. Mol. Nutr. Food Res. 55, 691-702. doi: 10.1002/mnfr.201000553.
150. Reboul, E., Klein, A., Bietrix, F., Gleize, B., Malezet-Desmoulins, C., Schneider, M., et al. (2006). Scavenger receptor class B type I (SR-BI) is involved in vitamin E transport across the enterocyte. J. Biol. Chem. 281, 4739-4745. doi: 10.1074/jbc.M509042200.
151. Rigotti, A. (2007). Absorption, transport, and tissue delivery of vitamin E. Mol. Aspects Med. 28, 423-436. doi: 10.1016/j.mam.2007.01.002.
152. Sahoo, S., Franzson, L., Jonsson, J. J., and Thiele, I. (2012). A compendium of inborn errors of metabolism mapped onto the human metabolic network. Mol. Biosyst. 8, 2545-2558. doi: 10.1039/C2MB25075F.
153. Sahoo, S., and Thiele, I. (2013). Predicting the impact of diet and enzymopathies on human small intestinal epithelial cells. Hum. Mol. Genet. 22, 2705-2722. doi: 10.1093/hmg/ddt119.
154. Said, H. M. (1999). Cellular uptake of biotin: mechanisms and regulation. J. Nutr. 129, 490S-493S.
155. Said, H. M. (2004). Recent advances in carrier-mediated intestinal absorption of water-soluble vitamins. Annu. Rev. Physiol. 66, 419-446. doi: 10.1146/annurev.physiol.66.032102.144611.
156. Said, H. M. (2011). Intestinal absorption of water-soluble vitamins in health and disease. Biochem. J. 437, 357-372. doi: 10.1042/BJ20110326.
157. Said, H. M., Hollander, D., and Mohammadkhani, R. (1993). Uptake of riboflavin by intestinal basolateral membrane vesicles: a specialized carrier-mediated process. Biochim. Biophys. Acta Biomembr. 1148, 263-268. doi: 10.1016/0005-2736(93)90138-p.
158. Said, H. M., Ortiz, A., and Ma, T. Y. (2003). A carrier-mediated mechanism for pyridoxine uptake by human intestinal epithelial Caco-2 cells: regulation by a PKA-mediated pathway. Am. J. Physiol. Cell Physiol. 285, C1219-C1225. doi: 10.1152/ajpcell.00204.2003.
159. Sanyal, S., and Menon, A. K. (2009). Flipping lipids: why an' what's the reason for? ACS Chem. Biol. 4, 895-909. doi: 10.1021/cb900163d.
160. Scalise, M., Galluccio, M., Accardi, R., Cornet, I., Tommasino, M., and Indiveri, C. (2012). Human OCTN2 (SLC22A5) is down-regulated in virus-and nonvirus-mediated cancer. Cell Biochem. Funct. 30, 419-425. doi: 10.1002/cbf.2816.
161. Schaffer, S. W., Jong, C. J., Ramila, K. C., and Azuma, J. (2010). Physiological roles of taurine in heart and muscle. J. Biomed. Sci. 17(Suppl. 1), S2. doi: 10.1186/1423-0127-17-S1-S2.
162. Scheepers, A., Joost, H. G., and Schurmann, A. (2004). The glucose transporter families SGLT and GLUT: molecular basis of normal and aberrant function. JPEN J. Parenter. Enteral Nutr. 28, 364-371. doi: 10.1177/0148607104028005364.
163. Schellenberger, J., Que, R., Fleming, R. M., Thiele, I., Orth, J. D., Feist, A. M., et al. (2011). Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox v2.0. Nat. Protoc. 6, 1290-1307. doi: 10.1038/nprot.2011.308.
164. Selimoglu, M. A., Aydogdu, S., Yagci, R. V., and Huseyinov, A. (2001). Plasma and liver carnitine status of children with chronic liver disease and cirrhosis. Pediatr. Int. 43, 391-395. doi: 10.1046/j.1442-200X.2001.01423.x.
165. Seow, H. F., Broer, S., Broer, A., Bailey, C. G., Potter, S. J., Cavanaugh, J. A., et al. (2004). Hartnup disorder is caused by mutations in the gene encoding the neutral amino acid transporter SLC6A19. Nat. Genet. 36, 1003-1007. doi: 10.1038/ng1406.
166. Shu, C., Shen, H., Hopfer, U., and Smith, D. E. (2001). Mechanism of intestinal absorption and renal reabsorption of an orally active ace inhibitor: uptake and transport of fosinopril in cell cultures. Drug Metab. Dispos. 29, 1307-1315.
167. Soghier, L. M., and Brion, L. P. (2006). Cysteine, cystine or N-acetylcysteine supplementation in parenterally fed neonates. Cochrane Database Syst. Rev. CD004869. doi: 10.1002/14651858.CD004869.pub2.
168. Srinivas, S. R., Prasad, P. D., Umapathy, N. S., Ganapathy, V., and Shekhawat, P. S. (2007). Transport of butyryl-L-carnitine, a potential prodrug, via the carnitine transporter OCTN2 and the amino acid transporter ATB(0,+). Am. J. Physiol. Gastrointest. Liver Physiol. 293, G1046-G1053. doi: 10.1152/ajpgi.00233.2007.
169. Stahl, A. (2004). A current review of fatty acid transport proteins (SLC27). Pflugers Arch. 447, 722-727. doi: 10.1007/s00424-003-1106-z.
170. Stahl, A., Gimeno, R. E., Tartaglia, L. A., and Lodish, H. F. (2001). Fatty acid transport proteins: a current view of a growing family. Trends Endocrinol. Metab. 12, 266-273. doi: 10.1016/S1043-2760(01)00427-1.
171. Stapleton, P. P., Charles, R. P., Redmond, H. P., and Bouchier-Hayes, D. J. (1997). Taurine and human nutrition. Clin. Nutr. 16, 103-108. doi: 10.1016/S0261-5614(97)80234-8.
172. Stewart, J. M. (2000). The cytoplasmic fatty-acid-binding proteins: thirty years and counting. Cell. Mol. Life Sci. 57, 1345-1359. doi: 10.1007/PL00000620.
173. Subramanian, V. S., Subramanya, S. B., Rapp, L., Marchant, J. S., Ma, T. Y., and Said, H. M. (2011). Differential expression of human riboflavin transporters-1,-2, and-3 in polarized epithelia: a key role for hRFT-2 in intestinal riboflavin uptake. Biochim. Biophys. Acta 1808, 3016-3021. doi: 10.1016/j.bbamem.2011.08.004.
174. Sweet, R., Paul, A., and Zastre, J. (2010). Hypoxia induced upregulation and function of the thiamine transporter, SLC19A3 in a breast cancer cell line. Cancer Biol. Ther. 10, 1101-1111. doi: 10.4161/cbt.10.11.13444.
175. Takeda, M., Khamdang, S., Narikawa, S., Kimura, H., Hosoyamada, M., Cha, S. H., et al. (2002). Characterization of methotrexate transport and its drug interactions with human organic anion transporters. J. Pharmacol. Exp. Ther. 302, 666-671. doi: 10.1124/jpet.102.034330.
176. Tamai, I., Senmaru, M., Terasaki, T., and Tsuji, A. (1995). Na(+)-and Cl(-)-dependent transport of taurine at the blood-brain barrier. Biochem. Pharmacol. 50, 1783-1793. doi: 10.1016/0006-2952(95)02046-2.
177. +-dependent glucose transporter, is an essential transporter for mannose, 1,5-anhydro-D-glucitol, and fructose. Life Sci. 76, 1039-1050. doi: 10.1016/j.lfs.2004.10.016.
178. Teijema, H. L., Van Gelderen, H. H., Giesberts, M. A., and Laurent De Angulo, M. S. (1974). Dicarboxylic aminoaciduria: an inborn error of glutamate and aspartate transport with metabolic implications, in combination with a hyperprolinemia. Metab. Clin. Exp. 23, 115-123. doi: 10.1016/0026-0495(74)90108-5.
179. Terada, T., Sawada, K., Saito, H., Hashimoto, Y., and Inui, K. (1999). Functional characteristics of basolateral peptide transporter in the human intestinal cell line Caco-2. Am. J. Physiol. 276, G1435-G1441.
180. Thangaraju, M., Cresci, G., Itagaki, S., Mellinger, J., Browning, D. D., Berger, F. G., et al. (2008). Sodium-coupled transport of the short chain fatty acid butyrate by SLC5A8 and its relevance to colon cancer. J. Gastrointest. Surg. 12, 1773-1781. discussion: 1781-1772. doi: 10.1007/s11605-008-0573-0.
181. Thangaraju, M., Gopal, E., Martin, P. M., Ananth, S., Smith, S. B., Prasad, P. D., et al. (2006). SLC5A8 triggers tumor cell apoptosis through pyruvate-dependent inhibition of histone deacetylases. Cancer Res. 66, 11560-11564. doi: 10.1158/0008-5472.CAN-06-1950.
182. Thiele, I., and Palsson, B. O. (2010a). A protocol for generating a high-quality genome-scale metabolic reconstruction. Nat. Protoc. 5, 93-121. doi: 10.1038/nprot.2009.203.
183. Thiele, I., and Palsson, B. O. (2010b). Reconstruction annotation jamborees: a community approach to systems biology. Mol. Syst. Biol. 6, 361. doi: 10.1038/msb.2010.15.
184. Thiele, I., Swainston, N., and Fleming, R. M. T., Hoppe, A., Sahoo, S., Aurich, M. K., et al. (2013). A community-driven global reconstruction of human metabolism. Nat. Biotechnol. 31, 419-425. doi: 10.1038/nbt.2488.
185. Thorens, B., and Mueckler, M. (2010). Glucose transporters in the 21st Century. Am. J. Physiol. Endocrinol. Metab. 298, E141-E145. doi: 10.1152/ajpendo.00712.2009.
186. Thorleifsson, S. G., and Thiele, I. (2011). rBioNet: A COBRA toolbox extension for reconstructing high-quality biochemical networks. Bioinformatics 27, 2009-2010. doi: 10.1093/bioinformatics/btr308.
187. +-coupled nutrient, micronutrient and drug transporters in the mammalian small intestine. Exp. Physiol. 92, 603-619. doi: 10.1113/expphysiol.2005.029959.
188. Thwaites, D. T., Brown, C. D., Hirst, B. H., and Simmons, N. L. (1993). Transepithelial glycylsarcosine transport in intestinal Caco-2 cells mediated by expression of H(+)-coupled carriers at both apical and basal membranes. J. Biol. Chem. 268, 7640-7642.
189. Tian, R., and Ingwall, J. S. (2008). How does folic acid cure heart attacks? Circulation 117, 1772-1774. doi: 10.1161/CIRCULATIONAHA.108.766105.
190. Tijssen, M. A. J., and Rees, M. I. (1993). Hyperekplexia. Seattle, WA: University of Washington.
191. Tolarova, M. (1982). Periconceptional supplementation with vitamins and folic acid to prevent recurrence of cleft lip. Lancet 2, 217. doi: 10.1016/S0140-6736(82)91063-7.
192. Toyoda, Y., and Ishikawa, T. (2010). Pharmacogenomics of human ABC transporter ABCC11 (MRP8): potential risk of breast cancer and chemotherapy failure. Anticancer Agents Med. Chem. 10, 617-624. doi: 10.2174/187152010794473975.
193. Tradtrantip, L., Tajima, M., Li, L., and Verkman, A. S. (2009). Aquaporin water channels in transepithelial fluid transport. J. Med. Invest. 56(Suppl.), 179-184. doi: 10.2152/jmi.56.179.
194. Uc, A., Stokes, J. B., and Britigan, B. E. (2004). Heme transport exhibits polarity in Caco-2 cells: evidence for an active and membrane protein-mediated process. Am. J. Physiol. Gastrointest. Liver Physiol. 287, G1150-G1157. doi: 10.1152/ajpgi.00157.2004.
195. Vadlapudi, A. D., Vadlapatla, R. K., Pal, D., and Mitra, A. K. (2012). Biotin uptake by T47D breast cancer cells: functional and molecular evidence of sodium-dependent multivitamin transporter (SMVT). Int. J. Pharm. 441, 535-543. doi: 10.1016/j.ijpharm.2012.10.047.
196. Vandenberg, R. J., Handford, C. A., Campbell, E. M., Ryan, R. M., and Yool, A. J. (2011). Water and urea permeation pathways of the human excitatory amino acid transporter EAAT1. Biochem. J. 439, 333-340. doi: 10.1042/BJ20110905.
197. Vannucci, S. J., Clark, R. R., Koehler-Stec, E., Li, K., Smith, C. B., Davies, P., et al. (1998). Glucose transporter expression in brain: relationship to cerebral glucose utilization. Dev. Neurosci. 20, 369-379. doi: 10.1159/000017333.
198. Vekony, N., Wolf, S., Boissel, J. P., Gnauert, K., and Closs, E. I. (2001). Human cationic amino acid transporter hCAT-3 is preferentially expressed in peripheral tissues. Biochemistry 40, 12387-12394. doi: 10.1021/bi011345c.
199. Verkman, A. S. (2005). More than just water channels: unexpected cellular roles of aquaporins. J. Cell Sci. 118, 3225-3232. doi: 10.1242/jcs.02519.
200. Verkman, A. S. (2012). Aquaporins in clinical medicine. Annu. Rev. Med. 63, 303-316. doi: 10.1146/annurev-med-043010-193843.
201. Verkman, A. S., Hara-Chikuma, M., and Papadopoulos, M. C. (2008). Aquaporins-new players in cancer biology. J. Mol. Med. 86, 523-529. doi: 10.1007/s00109-008-0303-9.
202. Wagner, M., and Trauner, M. (2005). Transcriptional regulation of hepatobiliary transport systems in health and disease: implications for a rationale approach to the treatment of intrahepatic cholestasis. Ann. Hepatol. 4, 77-99.
203. Wang, C., Uray, I. P., Mazumdar, A., Mayer, J. A., and Brown, P. H. (2012a). SLC22A5/OCTN2 expression in breast cancer is induced by estrogen via a novel intronic estrogen-response element (ERE). Breast Cancer Res. Treat. 134, 101-115. doi: 10.1007/s10549-011-1925-0.
204. Wang, Y., Eddy, J. A., and Price, N. D. (2012b). Reconstruction of genome-scale metabolic models for 126 human tissues using mCADRE. BMC Syst. Biol. 6:153. doi: 10.1186/1752-0509-6-153.
205. Watkins, D., and Rosenblatt, D. S. (2011). Inborn errors of cobalamin absorption and metabolism. Am. J. Med. Genet. C Semin. Med. Genet. 157, 33-44. doi: 10.1002/ajmg.c.30288.
206. Wert, S. E., Whitsett, J. A., and Nogee, L. M. (2009). Genetic disorders of surfactant dysfunction. Pediatr. Dev. Pathol. 12, 253-274. doi: 10.2350/09-01-0586.1.
207. West, A. R., and Oates, P. S. (2008). Mechanisms of heme iron absorption: current questions and controversies. World J. Gastroenterol. 14, 4101-4110. doi: 10.3748/wjg.14.4101.
208. Wilson, J. X. (2005). Regulation of vitamin C transport. Annu. Rev. Nutr. 25, 105-125. doi: 10.1146/annurev.nutr.25.050304.092647.
209. Wilson-O'Brien, A. L., Patron, N., and Rogers, S. (2010). Evolutionary ancestry and novel functions of the mammalian glucose transporter (GLUT) family. BMC Evol. Biol. 10:152. doi: 10.1186/1471-2148-10-152.
210. Wolf, S., Janzen, A., Vekony, N., Martine, U., Strand, D., and Closs, E. I. (2002). Expression of solute carrier 7A4 (SLC7A4) in the plasma membrane is not sufficient to mediate amino acid transport activity. Biochem. J. 364, 767-775. doi: 10.1042/BJ20020084.
211. Wood, I. S., and Trayhurn, P. (2003). Glucose transporters (GLUT and SGLT): expanded families of sugar transport proteins. Br. J. Nutr. 89, 3-9. doi: 10.1079/BJN2002763.
212. Wright, E. M., Hirayama, B. A., and Loo, D. F. (2007). Active sugar transport in health and disease. J. Intern. Med. 261, 32-43. doi: 10.1111/j.1365-2796.2006.01746.x.
213. Wright, E. M., Loo, D. D., and Hirayama, B. A. (2011). Biology of human sodium glucose transporters. Physiol. Rev. 91, 733-794. doi: 10.1152/physrev.00055.2009.
214. Wu, X., and Freeze, H. H. (2002). GLUT14, a duplicon of GLUT3, is specifically expressed in testis as alternative splice forms. Genomics 80, 553-557. doi: 10.1006/geno.2002.7010.
215. Xu, S., Flanagan, J. L., Simmons, P. A., Vehige, J., Willcox, M. D., and Garrett, Q. (2010). Transport of L-carnitine in human corneal and conjunctival epithelial cells. Mol. Vis. 16, 1823-1831.
216. Yabuuchi, H., Tamai, I., Nezu, J., Sakamoto, K., Oku, A., Shimane, M., et al. (1999). Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations. J. Pharmacol. Exp. Ther. 289, 768-773.
217. Yamauchi, A., Uchida, S., Kwon, H. M., Preston, A. S., Robey, R. B., Garcia-Perez, A., et al. (1992). Cloning of a Na(+)-and Cl(-)-dependent betaine transporter that is regulated by hypertonicity. J. Biol. Chem. 267, 649-652.
218. Yang, M., Gao, F., Liu, H., Yu, W. H., Zhuo, F., Qiu, G. P., et al. (2013). Hyperosmotic induction of aquaporin expression in rat astrocytes through a different MAPK pathway. J. Cell. Biochem. 114, 111-119. doi: 10.1002/jcb.24308.
219. Yang, Z., Philips, J. D., Doty, R. T., Giraudi, P., Ostrow, J. D., Tiribelli, C., et al. (2010). Kinetics and specificity of feline leukemia virus subgroup C receptor (FLVCR) export function and its dependence on hemopexin. J. Biol. Chem. 285, 28874-28882. doi: 10.1074/jbc.M110.119131.
220. Yao, Y., Yonezawa, A., Yoshimatsu, H., Masuda, S., Katsura, T., and Inui, K. (2010). Identification and comparative functional characterization of a new human riboflavin transporter hRFT3 expressed in the brain. J. Nutr. 140, 1220-1226. doi: 10.3945/jn.110.122911.
221. Yasui, M., Kwon, T. H., Knepper, M. A., Nielsen, S., and Agre, P. (1999). Aquaporin-6: an intracellular vesicle water channel protein in renal epithelia. Proc. Natl. Acad. Sci. U.S.A. 96, 5808-5813. doi: 10.1073/pnas.96.10.5808.
222. Zardoya, R., and Villalba, S. (2001). A phylogenetic framework for the aquaporin family in eukaryotes. J. Mol. Evol. 52, 391-404. doi: 10.1007/s002390010169.
223. Zempleni, J., Rucker, R. B., McCormick, D. B., and Suttie, J. W. (2007). Handbook of Vitamins. Boca Raton, FL: CRC press, Taylor and Francis Group.
224. +-glucose cotransporter SGLT1 from humans and rabbit. J. Physiol. (Lond.) 531, 631-644. doi: 10.1111/j.1469-7793.2001.0631h.x.
225. Zhao, R., Diop-Bove, N., Visentin, M., and Goldman, I. D. (2011). Mechanisms of membrane transport of folates into cells and across epithelia. Annu. Rev. Nutr. 31, 177-201. doi: 10.1146/annurev-nutr-072610-145133.
226. Zhao, R., and Goldman, I. D. (2003). Resistance to antifolates. Oncogene 22, 7431-7457. doi: 10.1038/sj.onc.1206946.
227. Zhao, Y., and Huang, J. (2011). Reconstruction and analysis of human heart-specific metabolic network based on transcriptome and proteome data. Biochem. Biophys. Res. Commun. 415, 450-454. doi: 10.1016/j.bbrc.2011.10.090.